Avadel Pharmaceuticals PLC
AVDLDelisted Feb 12, 2026- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001012477
Avadel Pharmaceuticals PLC was delisted on Feb 12, 2026; its insiders filed their last Form 4 on Feb 18, 2026; 208 institutions reported holding it in 13F filings for Q4 2025, worth $1.60B in total; no superinvestor held it.
Q3 2022 vs. Q2 2022
How the institutions holding Avadel Pharmaceuticals PLC changed between Q2 2022 and Q3 2022.
All holders in Q3 2022All holders in Q2 2022
| Measure | Q2 2022 | Of which not filed for Q3 2022 | Q3 2022 | Change |
|---|---|---|---|---|
| Holders | 82 | 2 | 76 | −4 |
| Shares | 33.7M | 13.0K | 31.4M | −2.34M (−6.9%) |
| Value | $82.3M | $32.1K | $157.2M | +$75.0M (+91.1%) |
2 institutions that held it in Q2 2022 haven't filed for Q3 2022 yet. Not filing isn't selling, so the changes leave them out.
New holders (10)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q3 2022 but not at the end of Q2 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Susquehanna International Group, LLP | 221,069 | $1.11M | 0.00% |
| Cubist Systematic Strategies, LLC | 51,809 | $260.0K | 0.00% |
| DeepCurrents Investment Group LLC | 13,283 | $67.0K | 0.00% |
| Virtu Financial LLC | 10,541 | $53.0K | 0.00% |
| SG Americas Securities, LLC | 10,021 | $50.0K | 0.00% |
| Journey Strategic Wealth LLC | 10,000 | $50.0K | 0.01% |
| Quantbot Technologies LP | 6,900 | $34.0K | 0.00% |
| US Bancorp | 2,010 | $10.0K | 0.00% |
| Simplex Trading, LLC | 2,100 | $10.0K | 0.00% |
| China Universal Asset Management Co., Ltd. | 552 | $3.00K | 0.00% |
Sold out (14)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q2 2022 and filed for Q3 2022 without it.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| Millennium Management LLC | 212,590 | $519.0K |
| Jump Financial, LLC | 56,300 | $137.0K |
| Raymond James & Associates | 34,141 | $83.0K |
| Jane Street Group, LLC | 33,220 | $81.0K |
| Iridian Asset Management LLC | 30,000 | $73.0K |
| Aquatic Capital Management LLC | 26,600 | $65.0K |
| XTX Topco Ltd | 13,093 | $32.0K |
| Marshall Wace, LLP | 11,081 | $27.0K |
| BNP Paribas Arbitrage, SA | 3,298 | $8.05K |
| The PNC Financial Services Group, Inc. | 500 | $1.00K |
| Captrust Financial Advisors | 344 | $1.00K |
| Cutler Group LP | 698 | $1.00K |
| Royal Bank of Canada | 200 | $0 |
| International Biotechnology Trust PLC | 122 | – |
Not filed for Q3 2022 yet (2)
Institutions that held Avadel Pharmaceuticals PLC at the end of Q2 2022 and haven't filed a 13F for Q3 2022. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2022 | Value, Q2 2022 |
|---|---|---|
| B. Riley Wealth Management, Inc. | 13,000 | $32.0K |
| Exane Derivatives | 33 | $81 |